MULTI-KINASE INHIBITOR COMPOUND, AND CRYSTAL FORM AND USE THEREOF

The present invention relates to a compound as represented by formula (I) or a pharmaceutically acceptable salt and stereoisomer thereof, wherein R1, R2, X, Y, P, W, and Ar are as defined in the description. The compound of formula (I) of the present invention can be used in the preparation of a dru...

Full description

Saved in:
Bibliographic Details
Main Author WU, Frank
Format Patent
LanguageChinese
English
French
Published 21.06.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a compound as represented by formula (I) or a pharmaceutically acceptable salt and stereoisomer thereof, wherein R1, R2, X, Y, P, W, and Ar are as defined in the description. The compound of formula (I) of the present invention can be used in the preparation of a drug for treating cancers mediated by multi-kinase abnormalities. Also provided is a crystal form I of a compound 4-(5-(2-chlorophenyl)-3-methyl-2,10-dihydropyrazole[4,3-b]pyrido[4,3-e] [1,4]diazepin-8-yl)morpholine, wherein in an X-ray powder diffraction pattern of crystal form I, there are characteristic peaks at 7.4 ± 0.2°, 17.9 ± 0.2°, 18.9 ± 0.2°, 19.4 ± 0.2°, 21.5 ± 0.2°, and 23.7 ± 0.2°. La présente invention concerne un composé tel que représenté par la formule (I) ou un sel pharmaceutiquement acceptable et un stéréoisomère de celui-ci, dans la formule R1, R2, X, Y, P, W et Ar sont tels que définis dans la description. Le composé de formule (I) de la présente invention peut être utilisé dans la préparation d'u
Bibliography:Application Number: WO2017CN115698